Search Results - "Dolce, D."

Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age by Fevola, C., Dolce, D., Tosco, A., Padoan, R., Daccò, V., Claut, L., Schgor, T., Sepe, A., Timpano, S., Fabrizzi, B., Piccinini, P., Taccetti, G., Bonomi, P., Terlizzi, V.

“…The identification of cystic fibrosis screening-positive, inconclusive diagnosis (CFSPID) in infants is a controversial outcome of newborn screening for cystic…”
Get full text

WS03.2 Longitudinal metagenomic analysis of the airways of patients with cystic fibrosis to uncover microbial signatures of lung disease progression by Bacci, G, Armanini, F, Taccetti, G, Lucidi, V, Dolce, D, Morelli, P, Fiscarelli, E.V, Segata, N, Mengoni, A, Bevivino, A

Get full text

71 Pseudomonas aeruginosa in paranasal sinuses and in lower airways in cystic fibrosis patients by Dolce, D, Bresci, S, Masi, E, Campana, S, Braggion, C, Taccetti, G

“…Objective The paranasal sinuses could be a site of P. aeruginosa (PA) infection and/or reservoir for episodes of pulmonary re-infection in CF patients. The aim…”
Get full text

101 Longitudinal study of methicillin-resistant Staphylococcus aureus genetic background isolated from cystic fibrosis patients by Dolce, D, Ravenni, N, Campana, S, Camera, E, Neri, S, Braggion, C, Manara, S, Pasolli, E, Armanini, F, Segata, N, Taccetti, G

Get full text

121 Anti-Pseudomonas aeruginosa antibodies and microbiological outcome in not chronically infected patients by Dolce, D, Ravenni, N, Mergni, G, Braggion, C, Campana, S, Taccetti, G

Get full text

88 Use of MALDI-TOF-MS for identification of anaerobic bacteria in CF patients by Ravenni, N, Cocchi, P, Dolce, D, Mergni, G, Taccetti, G, Braggion, C, Campana, S

Get full text

55 CA-MRSA and HA-MRSA persistent infection and pulmonary function: a multicenter longitudinal study by Dolce, D, Campana, S, Ravenni, N, Camera, E, Neri, S, Cariani, L, Colombo, C, Fiscarelli, E.V, Lucidi, V, Raia, V, Iula, D.V, Braggion, C, Taccetti, G

Get full text

99 Investigating the airway microbiome in cystic fibrosis patients with normal and severe pulmonary function decline: an opportunity for a personalized microbiome-based therapy by Bacci, G, Paganin, P, Segata, N, Armanini, F, Taccetti, G, Dolce, D, Alessandri, A. De, Morelli, P, Tuccio, V, Fiscarelli, E.V, Lucidi, V, Mengoni, A, Bevivino, A

Get full text

P017 Sweat test: different clinical questions require different lab reports by Cirilli, N., Dolce, D.

Get full text

156 Chronic airway colonization by Aspergillus fumigatus (Af) in patients with cystic fibrosis (CF): Does it contribute to lung function decline? by Braggion, C, Pasotto, R, Mergni, G, Taccetti, G, Dolce, D, Cocchi, P, Campana, S

Get full text

165 Evaluation of antibody against Pseudomonas aeruginosa in intermittently infected cystic fibrosis patients by Dolce, D, Campana, S, Braggion, C, Taccetti, G

Get full text

125 Investigation of cystic fibrosis airway microbiome in patients showing a severe decline in lung function and not responding to conventional antimicrobial therapy by Bevivino, A, Fiscarelli, E, Mengoni, A, Taccetti, G, Manno, G, Paganin, P, Tuccio, V, Chiancianesi, M, Dolce, D, Morelli, P

Get full text

Chromogenic versus cetrimide-based media for Pseudomonas aeruginosa isolation by Ravenni, N, Dolce, D, Cocchi, P, Braggion, C, Campana, S

Get full text

Early Pseudomonas aeruginosa infection: is susceptibility testing justified? by Macdonald, D, Govan, J, Cuthbertson, L, Doherty, C, Campana, S, Dolce, D, Taccetti, G

Get full text

101 Changes in airways sampling and microorganisms isolation after elexacaftor/tezacaftor/ivacaftor therapy in people with cystic fibrosis: a longitudinal study by Dolce, D., Campana, S., Ravenni, N., Orioli, T., Camera, E., Fevola, C., Francalanci, M., Taccetti, G.

Get full text

P221 Airways viral infections in children and adults with cystic fibrosis by Campana, S., Ravenni, N., Dolce, D., Camera, E., Orioli, T., Taccetti, G.

Get full text

P061 Effect of elexacaftor/tezacaftor/ivacaftor on inflammatory parameters and bacterial respiratory cultures in children and adolescents with cystic fibrosis: a retrospective, dual-center cohort study by Pepe, A., Fevola, C., Dolce, D., Campana, S., Taccetti, G., Salvatore, D., Terlizzi, V.

Get full text

611 Quantity-not-sufficient sweat test in children undergoing newborn screening for cystic fibrosis by Dolce, D., Campana, S., Ravenni, N., Camera, E., Orioli, T., Cavicchi, M., Terlizzi, V., Taccetti, G.

Get full text

713 Isolation of non-aeruginosa Pseudomonas from cystic fibrosis airways: a consequence of elexacaftor-tezacaftor-ivacaftor therapy? Results of a multicenter study by Campana, S., Ravenni, N., Dolce, D., Orioli, T., Camera, E., Francalanci, M., Vitullo, P., Lucanto, M., Taccetti, G.

Get full text

71 No SARS-CoV-2 viral upper and lower airways infection in cystic fibrosis: evaluation of clinical outcomes by Dolce, D., Campana, S., Ravenni, N., Fevola, C., Orioli, T., Camera, E., Francalanci, M., Innocenti, D., Masi, E., Taccetti, G.

Get full text